Tonix jumps on re­jigged phase III for PTSD drug; MeiraGTx scores an­oth­er NIH deal; Op­Gen, Qi­a­gen join hands to de­tect su­per­bugs

→ Af­ter a Phase III tri­al test­ing its PTSD drug, Ton­mya, in­volv­ing pa­tients that suf­fered trau­ma dur­ing mil­i­tary ser­vice since 2001, was pre­ma­ture­ly halt­ed fol­low­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER